Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs JD.Com Inc (JD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs JD.Com Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.24 (market cap $30.93B), while JD.Com Inc trades at $26.76 (market cap $36.93B). The key difference: JD.Com Inc is the larger of the two by market cap, and JD.Com Inc pays the higher dividend (3.75%). Which is the better fit depends on your goals.
| GEHC | JD | |
|---|---|---|
Market Cap | $30.93B | $36.93B |
Volume | 5,033,451 | 6,680,917 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $34.53 |
52-Week Low | $59.48 | $25.19 |
Enterprise Value | $39.39B | $19.54B |
Dividend Yield | 0.23% | 3.75% |
Typical Hold Time | — | 86 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
JD.com trades at $26.78, up 0.22% with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth to $1.31 trillion in 2025 but faces margin compression with net income declining to $19.63 billion. Valuation metrics appear attractive with P/E of 17.71 and P/S of 0.2, while analyst consensus remains bullish with a $35.38 price target. Recent news highlights JD's potential EU approval for its $2.5 billion Ceconomy acquisition and Michael Burry's increased position.
JD presents a compelling value opportunity with deep discount to intrinsic value estimates of $50-60, though near-term headwinds include Chinese regulatory scrutiny and competitive pressures. The stock's risk-reward appears favorable given strong cash flow generation and robust balance sheet with $234 billion cash position, but investors should monitor execution on international expansion and margin recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →
